Regulatory status by jurisdiction: difference between revisions
Diff·revision 17 → 18·15:01, 25 Aug 2025
Difference between revision 17 and revision 18 of Regulatory status by jurisdiction. 2 lines changed; the page grew by 182 bytes.
| Revision 17 — 06:52, 30 Jul 2025 RotationRosalind (talk) add the effective date to the regulatory table 4,262 bytes ±0 | Revision 18 — 15:01, 25 Aug 2025 ImportRecordIna (talk) add the patent-expiry statement, attributed and dated 4,444 bytes +182 | ||
|---|---|---|---|
| 39 | Border treatment follows from status but is not identical to it, since enforcement discretion and declaration also operate. See [[Customs seizure]] and [[Personal importation policy]].{{r|fda_pip}} | 39 | Border treatment follows from status but is not identical to it, since enforcement discretion and declaration also operate. See [[Customs seizure]] and [[Personal importation policy]].{{r|fda_pip}} |
| 40 | 40 | ||
| + | 41 | This wiki sells nothing, is independent of every organisation named in it, and gives no legal advice. Research-use compounds are not approved for human administration.{{r|usp1503}} | |
| + | 42 | ||
| 41 | == References == | 43 | == References == |
| 42 | {{reflist}} | 44 | {{reflist}} |